申请人:KYOWA HAKKO KOGYO CO., LTD.
公开号:EP1671957A1
公开(公告)日:2006-06-21
An antitumor agent comprising a thiadiazoline derivative represented by the general formula (I), or a pharmacologically acceptable salt thereof as an active ingredient:
(wherein Z represents a sulfur atom and the like, R1 represents substituted or unsubstituted lower alkynyl and the like, R2 represents a hydrogen atom and the like, R3 represents substituted or unsubstituted lower alkyl and the like, and R4 represents substituted or unsubstituted aryl and the like), and the like are provided.
一种抗肿瘤制剂,其活性成分包括通式 (I) 所代表的噻二唑啉衍生物或其药理上可接受的盐:
(其中 Z 代表硫原子等,R1 代表取代或未取代的低级炔基等,R2 代表氢原子等,R3 代表取代或未取代的低级烷基等,R4 代表取代或未取代的芳基等)等。